Sells molecular diagnostic tests for thyroid cancer to reduce unnecessary surgeries.
Industry: Health Care
First Day Return: +1.9%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/20/2013 |
Offer Price | $13.00 |
Price Range $13.00 - $15.00 | |
Offer Shares (mm) | 5.0 |
Deal Size ($mm) | $65 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/29/2013 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $65 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | San Francisco, CA, United States |
Founded | 2006 |
Employees at IPO | 107 |
Website www.veracyte.com |